Hemab Therapeutics Holdings, Inc. logo

Hemab Therapeutics Holdings, Inc. (COAG)

Market Closed
15 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS)
$
32. 52
+2.58
+8.6172%
$
1.39B Market Cap
- P/E Ratio
- Div Yield
478,279 Volume
- Eps
$ 29.94
Previous Close
Analysts:
Add Transaction
Day Range
30.2 33.5
Year Range
23 55.42
Want to track COAG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Hemab Therapeutics Holdings, Inc. Analysts

Name Quantity Cost Value Profit ($) Gain (%)
MGK
Michael G. King Jr. Rodman & Renshaw
1,458.7 $44,329.83 $46,590.81 $2,260.98 5.1%